Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Optex receives NIH grant to develop Catarex

May 10, 1996

Sterizone System to be evaluated in Cornell study

May 10, 1996

CR1 technology licensed to CytoTherapeutics

May 10, 1996

Gryphon, SKB to study mirror image proteins

May 10, 1996

Hyal to study agents for macular degeneration

May 10, 1996

RiboGene and Abbott collaborate on antifungal drugs

May 10, 1996

BioChem, Oncogene to investigate treatments for HCV, HIV

May 10, 1996

Gensia coagulation monitoring system enters phase I

May 3, 1996

Stealth liposomes possess prolonged stability

May 3, 1996

Cadus/Solvay yeast-based drug discovery program receives boost from EC

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for February 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...